David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$345M |
| 2 |
Biogen
BIIB
|
+$281M |
| 3 |
Bausch Health
BHC
|
+$244M |
| 4 |
SPDR Gold Trust
GLD
|
+$238M |
| 5 |
Coca-Cola
KO
|
+$206M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
LyondellBasell Industries
LYB
|
+$397M |
| 2 |
AGN
Allergan Inc
AGN
|
+$374M |
| 3 |
TWC
TIME WARNER CABLE INC NEW COM STK
TWC
|
+$347M |
| 4 |
Microsoft
MSFT
|
+$265M |
| 5 |
IBM
IBM
|
+$251M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Energy | 10.34% |
| 2 | Technology | 9.79% |
| 3 | Consumer Discretionary | 9.73% |
| 4 | Healthcare | 8.68% |
| 5 | Financials | 8.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AVB
751
DELISTED
AvalonBay Communities
AVB
| $14.5M | 0.02% |
+83,076
| New | +$14.4M |
|
752
Madison Square Garden
MSGS
$9.69B
| $14.4M | 0.02% |
238,887
+69,399
| +41% | +$3.82M |
|
753
Fidelity National Financial
FNF
$12.7B
| $14.4M | 0.02% |
564,860
+375,619
| +198% | +$9.47M |
|
754
United Parks & Resorts
PRKS
$2.03B
| $14.4M | 0.02% |
745,736
-147,131
| -16% | -$2.71M |
|
755
Brookdale Senior Living
BKD
$2.89B
| $14.3M | 0.02% |
378,815
-391,014
| -51% | -$14.3M |
|
|
RDS.A
756
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
| $14.3M | 0.02% |
256,373
+208,275
| +433% | +$12.3M |
|
757
LiveRamp
RAMP
$2.29B
| $14.3M | 0.02% |
772,430
-199,980
| -21% | -$3.84M |
|
758
Rogers Communications
RCI
$19.7B
| $14.3M | 0.02% |
426,500
+171,500
| +67% | +$6.18M |
|
759
Charles River Laboratories
CRL
$14.3B
| $14.2M | 0.02% |
179,686
+74,514
| +71% | +$5.5M |
|
760
McKesson
MCK
$102B
| $14.2M | 0.02% |
62,968
+39,148
| +164% | +$8.68M |
|
761
CALL
Sherwin-Williams
SHW
$84.2B
| $14.2M | 0.02% |
150,000
-294,600
| -66% | -$27.5M |
|
|
TGI
762
DELISTED
Triumph Group
TGI
| $14.2M | 0.02% |
237,574
-100,573
| -30% | -$6.04M |
|
763
MDU Resources
MDU
$4.2B
| $14.2M | 0.02% |
1,746,993
+436,427
| +33% | +$3.7M |
|
764
Crown Holdings
CCK
$13B
| $14.1M | 0.02% |
261,373
+222,098
| +565% | +$11M |
|
765
Unum
UNM
$14.2B
| $14.1M | 0.02% |
+417,931
| New | +$13.9M |
|
|
AET
766
PUT
DELISTED
Aetna Inc
AET
| $14.1M | 0.02% |
132,300
+17,800
| +16% | +$1.74M |
|
767
CALL
GE Aerospace
GE
$355B
| $14.1M | 0.02% |
118,291
-28,273
| -19% | -$3.37M |
|
|
PPS
768
DELISTED
Post Properties
PPS
| $14.1M | 0.02% |
246,863
+209,027
| +552% | +$12.3M |
|
769
Designer Brands
DBI
$297M
| $14M | 0.02% |
380,739
+82,543
| +28% | +$3.03M |
|
770
Lands' End
LE
$377M
| $14M | 0.02% |
391,200
-108,800
| -22% | -$4.32M |
|
771
CALL
Elevance Health
ELV
$87.3B
| $14M | 0.02% |
90,800
-12,300
| -12% | -$1.75M |
|
|
MWW
772
DELISTED
Monster Worldwide Inc
MWW
| $14M | 0.02% |
2,211,114
-474,156
| -18% | -$2.6M |
|
773
Ironwood Pharmaceuticals
IRWD
$682M
| $14M | 0.02% |
1,044,652
+184,696
| +21% | +$2.42M |
|
774
Molson Coors Class B
TAP
$8.02B
| $14M | 0.02% |
187,689
+167,416
| +826% | +$12.6M |
|
|
775
PUT
Coca-Cola
KO
$396B
| $14M | 0.02% |
344,500
-565,500
| -62% | -$23.7M |
|
Similar funds
David Shaw's Q1 2015 Portfolio in Review
As of Q1 2015, David Shaw held 4,408 positions worth $65.3B, down 16% from $77.8B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
David Shaw withdrew a net $15B in Q1 2015, closing 828 positions and reducing 1,784 holdings. Its most notable exit was Allergan Inc, an estimated $374M position sold in full.
By sector, the portfolio is most concentrated in Energy at 10% of assets, up from 8.6% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, David Shaw opened a new position in SPDR Gold Trust worth $231M.
- David Shaw's largest Q1 2015 buy was SPDR Gold Trust: 2,033,000 shares worth $231M.
- David Shaw added most to State Street SPDR S&P 500 ETF Trust in Q1 2015, an estimated $345M increase.
- David Shaw's biggest Q1 2015 reduction was LyondellBasell Industries, cutting an estimated $397M.
- David Shaw fully exited Allergan Inc in Q1 2015, selling an estimated $374M.
- David Shaw's ten largest holdings make up 11% of its $65.3B portfolio in Q1 2015.
- David Shaw opened 448 new positions and closed 828 in Q1 2015.
- David Shaw's portfolio value fell 16% quarter-over-quarter to $65.3B.
Based on D.E. Shaw & Co's 13F filing for Q1 2015, filed 15 May 2015.